Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on: February 20,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on:February 20,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on: May 06,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on:May 06,2024

After breast cancer: 5 changes you can make to stay healthy

by Marina Reeves, Caroline Olivia Terranova, Kelly D'cunha and Sandra Hayes,The ConversationCredit: PexelsEvery year, more than20,000 Australians—mostly women—are diagnosed with breast

Updated on: January 02,2024

After breast cancer: 5 changes you can make to stay healthy

by Marina Reeves, Caroline Olivia Terranova, Kelly D'cunha and Sandra Hayes,The ConversationCredit: PexelsEvery year, more than20,000 Australians—mostly women—are diagnosed with breast

Updated on:January 02,2024

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on: March 30,2024

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on:March 30,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024

Lymph node-like structures may trigger the demise of cancer tumors

byJohns Hopkins University School of MedicineTertiary lymphoid structure. Credit: Daniel ShuA newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunoth

Updated on: November 11,2024

Lymph node-like structures may trigger the demise of cancer tumors

byJohns Hopkins University School of MedicineTertiary lymphoid structure. Credit: Daniel ShuA newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunoth

Updated on:November 11,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on: January 26,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on:January 26,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on: January 22,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on:January 22,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on: March 15,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on:March 15,2024